Atea Pharmaceuticals Inc (AVIR)
3.24
+0.08
(+2.53%)
USD |
NASDAQ |
Nov 21, 15:59
Atea Pharmaceuticals Price: 3.24 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 3.12 | 3.16 | 3.095 | 3.16 | 182019.0 |
| Nov 19, 2024 | 3.13 | 3.17 | 3.115 | 3.14 | 94277.00 |
| Nov 18, 2024 | 3.22 | 3.315 | 3.155 | 3.17 | 121373.0 |
| Nov 15, 2024 | 3.35 | 3.35 | 3.18 | 3.22 | 313823.0 |
| Nov 14, 2024 | 3.38 | 3.43 | 3.31 | 3.31 | 208898.0 |
| Nov 13, 2024 | 3.39 | 3.475 | 3.35 | 3.35 | 207985.0 |
| Nov 12, 2024 | 3.38 | 3.425 | 3.32 | 3.33 | 265329.0 |
| Nov 11, 2024 | 3.50 | 3.55 | 3.33 | 3.36 | 243701.0 |
| Nov 08, 2024 | 3.49 | 3.57 | 3.430 | 3.50 | 170075.0 |
| Nov 07, 2024 | 3.51 | 3.60 | 3.415 | 3.44 | 282101.0 |
| Nov 06, 2024 | 3.45 | 3.62 | 3.43 | 3.58 | 380581.0 |
| Nov 05, 2024 | 3.32 | 3.365 | 3.285 | 3.36 | 93537.00 |
| Nov 04, 2024 | 3.27 | 3.405 | 3.25 | 3.35 | 137566.0 |
| Nov 01, 2024 | 3.28 | 3.31 | 3.246 | 3.29 | 78569.00 |
| Oct 31, 2024 | 3.28 | 3.305 | 3.22 | 3.24 | 193233.0 |
| Oct 30, 2024 | 3.45 | 3.45 | 3.28 | 3.28 | 125239.0 |
| Oct 29, 2024 | 3.40 | 3.43 | 3.335 | 3.39 | 119383.0 |
| Oct 28, 2024 | 3.36 | 3.48 | 3.355 | 3.42 | 115346.0 |
| Oct 25, 2024 | 3.42 | 3.447 | 3.35 | 3.35 | 86513.00 |
| Oct 24, 2024 | 3.49 | 3.53 | 3.30 | 3.38 | 154742.0 |
| Oct 23, 2024 | 3.53 | 3.56 | 3.40 | 3.48 | 99896.00 |
| Oct 22, 2024 | 3.56 | 3.595 | 3.51 | 3.56 | 52247.00 |
| Oct 21, 2024 | 3.82 | 3.86 | 3.585 | 3.59 | 180502.0 |
| Oct 18, 2024 | 3.74 | 3.84 | 3.701 | 3.82 | 157573.0 |
| Oct 17, 2024 | 3.79 | 3.80 | 3.705 | 3.73 | 116099.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.80
Minimum
Nov 22 2023
88.44
Maximum
Feb 08 2021
13.26
Average
5.175
Median
Price Benchmarks
| McKesson Corp | 628.18 |
| Pfizer Inc | 25.12 |
| Doximity Inc | 48.02 |
| Immuneering Corp | 2.11 |
| CEL-SCI Corp | 0.6024 |
Price Related Metrics
| PS Ratio | 0.7746 |
| Price to Book Value | 0.5968 |
| Earnings Yield | -63.89% |
| Market Cap | 273.66M |
| Operating PE Ratio | 1.967 |
| Normalized PE Ratio | 2.382 |